What is Behavioral Diagnostics?
Behavioral Diagnostics is a pioneering healthcare company specializing in early-detection tests for substance addiction and cancer development. Their innovative products, including the Lung CA Screening, Smoke Signature, and Alcohol Signature tests, utilize advanced epigenetic methods and artificial intelligence to provide precise risk assessments. The company serves a diverse clientele, including healthcare providers, insurers, employers, and patients, aiming to enhance personal and family well-being through actionable health insights. Committed to revolutionizing cancer care, Behavioral Diagnostics focuses on early detection and prevention strategies to improve overall health outcomes.
How much funding has Behavioral Diagnostics raised?
Behavioral Diagnostics has raised a total of $85K across 1 funding round:
Debt
$85K
Debt (2021): $85K with participation from PPP
Key Investors in Behavioral Diagnostics
PPP
Public-Private Partnership
What's next for Behavioral Diagnostics?
With this latest round of significant backing, Behavioral Diagnostics is poised for substantial expansion. The infusion of capital is expected to accelerate the development and deployment of their advanced epigenetic and AI-driven diagnostic tools. This strategic investment will likely fuel further research into early detection methods for addiction and cancer, enhance market penetration across healthcare providers, insurers, and employers, and solidify their position as a leader in preventative healthcare.
See full Behavioral Diagnostics company page
